CRISPR Gene Editing Global Market Report 2024 by The Business Research Company | Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., GenScript, Integrated DNA Technologies Inc., Takara Bio Inc., OriGene Technologies Inc., Intellia Therap

The CRISPR gene editing market size has grown exponentially in recent years. It will grow from $1.78 billion in 2023 to $2.26 billion in 2024 at a compound annual growth rate (CAGR) of 26.9%. The growth in the historic period can be attributed to increased demand for genome editing technologies, rise in government funding, increased cancer cases, increased prevalence of chronic diseases, increased awareness about CRISPR technology, rise healthcare infrastructure.

The CRISPR gene editing market size is expected to see exponential growth in the next few years. It will grow to $5.92 billion in 2028 at a compound annual growth rate (CAGR) of 27.2%. The growth in the forecast period can be attributed to increasing prevalence of genetic disorders, growing emphasis on precision medicine, rising investment in CRISPR research and development, increasing geriatric population, growing prominence for the gene therapy procedures. Major trends in the forecast period include advancements in gene editing technology, expansion in the number of research studies, drug discovery and development, innovation in delivery methods, adoption of CRISPR-edited agriculture.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=15549&type=smp

CRISPR Gene Editing Market Major Segments
The CRISPR gene editing market covered in this report is segmented -

1) By Type: CRISPR-Associated Nuclease (Cas Nuclease), Guide Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA) Ligase, Restriction Endonuclease, Other Types
2) By Services: Design Tools, Plasmid And Vector, CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA), Delivery System Products, Other Services
3) By Technology: CRISPR Or Cas9, Zinc Finger Nucleases, Other Technologies
4) By Application: Agricultural, Biomedical , Industrial, Genome Engineering, Disease Models, Functional Genomics, Other Applications
5) By End User: Academic Institutes And Research Centers, Biotechnology Companies, Contract Research Organizations (CROs), Pharmaceutical And Biopharmaceutical Companies

Key Driver - Elevated Prevalence Of Cardiovascular Diseases Boosts Hemodynamic Monitoring Systems Market Growth

The increasing prevalence of genetic disorders is expected to propel the growth of the CRISPR gene editing market going forward. A genetic disorder is a health problem caused by genome abnormalities, which include mutations in a single gene (monogenic), multiple genes (polygenic), or chromosomal abnormalities. The prevalence of genetic disorders is increasing due to genetic mutations, aging populations, and consanguineous marriage. CRISPR gene editing significantly aids in managing genetic disorders by providing precise and targeted modifications to the DNA. Further, scientists use CRISPR to identify and correct specific mutations causing genetic disorders, restore normal function, and alleviate disease symptoms, as seen in conditions such as cystic fibrosis and sickle cell anemia. For instance, in April 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, about 6,000 babies born in the United States have Down syndrome each year, which occurs in about 1 in every 700 babies. Therefore, the increasing prevalence of genetic disorders is driving the growth of the CRISPR gene editing market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=15549&type=smp

Prominent Trend - Innovative CRISPR Gene Editing Tools Revolutionize Genetic Analysis

Major companies operating in the CRISPR gene editing market are focused on developing innovative products, such as CRISPR gene editing tools, to provide researchers with reliable and efficient solutions, enabling rapid and simplified analysis of gene editing experiments. CRISPR gene editing tools are a solution for CRISPR genome editing experiments that will allow researchers to study edited genetic material with unprecedented speed and efficiency, determining how their interventions have altered the function of the DNA sequence in question. For instance, in June 2021, QIAGEN, a Germany-based provider of sample and assay technologies for molecular diagnostics, academic research, and pharmaceutical research, launched the QIAprep& and CRISPR Kit and CRISPR Q-Primer. These tools are designed to determine cells edited with CRISPR technologies, offering a sensitive, all-in-one solution for defining knock-outs and knock-ins produced during gene editing. The QIAprep&CRISPR Kit and CRISPR Q-Primer Solutions integrate liquid-based sample preparation with downstream PCR detection and Sanger sequencing, resulting in a seven-day reduction in experiment time compared to conventional approaches.

CRISPR Gene Editing Market Players
Major companies operating in the CRISPR gene editing market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., GenScript, Integrated DNA Technologies Inc., Takara Bio Inc., OriGene Technologies Inc., Intellia Therapeutics Inc., New England Biolabs, Synthego, Arbor Biotechnologies Inc., Rockland Immunochemicals Inc. , Cellectis, Editas Medicine, Caribou Biosciences Inc., System Biosciences LLC, Applied StemCell, Addgene, Mirus Bio LLC, Excision BioTherapeutics Inc., GeneCopoeia Inc., ToolGen Inc., Cellecta Inc., CRISPR Therapeutics, ERS Genomics Limited

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the CRISPR gene editing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. CRISPR Gene Editing Market Report Structure
3. CRISPR Gene Editing Market Trends And Strategies
4. CRISPR Gene Editing Market - Macro Economic Scenario
5. CRISPR Gene Editing Market Size And Growth
…..
27. CRISPR Gene Editing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.